Natera Cash Conversion Cycle 2011-2026 | NTRA

Annual Cash Conversion Cycle Natera

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
81.5	58.5	61.6	72.3	86	15.5	8.89	13.7	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
86	8.89	49.8

Quarterly Cash Conversion Cycle Natera

2024-Q3	2023-Q4	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
60.7	-	-	-	-	-	68.1	-	60.8	60.3	49.8	-	73	108	81.3	58.5	71.1	73.8	82	82.6	84.8	87.8	77.2	76	72.3	76.3	49.6	24.8	22.7	23.5	14.2	10.1	11.3	11.3	11.3	10.9	5.86	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
108	5.86	53.3

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Biodesix BDSX	41.7	$ 15.21	3.54 %	$ 1.97 B	USA
Bioventus BVS	224	$ 9.12	1.33 %	$ 608 M	USA
Biomerica BMRA	172	$ 2.12	-0.47 %	$ 4.87 M	USA
Fulgent Genetics FLGT	42.4	$ 16.37	0.24 %	$ 495 M	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Lantheus Holdings LNTH	97.3	$ 75.01	-0.96 %	$ 5.06 B	USA
Medpace Holdings MEDP	50.4	$ 460.9	0.87 %	$ 13.3 B	USA
Myriad Genetics MYGN	49.3	$ 4.77	2.36 %	$ 442 M	USA
National Research Corporation NRC	29.4	$ 17.42	-0.51 %	$ 390 M	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
Pacific Biosciences of California PACB	185	$ 1.39	-0.36 %	$ 417 M	USA
Co-Diagnostics CODX	299	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Precipio PRPO	-3.19	$ 26.85	-0.3 %	$ 34.8 M	USA
Personalis PSNL	-11.5	$ 7.7	1.18 %	$ 456 M	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
RadNet RDNT	34.5	$ 60.0	-2.83 %	$ 4.51 B	USA
Charles River Laboratories International CRL	65	$ 159.79	1.13 %	$ 7.92 B	USA
IQVIA Holdings IQV	73.9	$ 165.38	-0.95 %	$ 28.4 B	USA
Senseonics Holdings SENS	36.1	$ 6.74	1.81 %	$ 281 M	USA
Sotera Health Company SHC	33.5	$ 13.89	0.07 %	$ 3.94 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	166	$ 1.24	-15.07 %	$ 6.75 M	USA
Neuronetics STIM	17.3	$ 1.49	-7.19 %	$ 98.3 M	USA
Mettler-Toledo International MTD	66.4	$ 1 256.48	1.41 %	$ 25.9 B	Schweiz
Interpace Biosciences IDXG	44.9	$ 1.71	0.73 %	$ 7.5 M	USA
IDEXX Laboratories IDXX	103	$ 574.14	-0.76 %	$ 46.2 B	USA
Illumina ILMN	142	$ 125.44	1.33 %	$ 19.9 B	USA
ICON Public Limited Company ICLR	62	$ 101.04	0.68 %	$ 8.33 B	Irlanda
Guardant Health GH	79.6	$ 85.0	0.05 %	$ 10.7 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Twist Bioscience Corporation TWST	83.6	$ 45.99	3.35 %	$ 2.75 B	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	40.3	$ 265.75	0.5 %	$ 22.1 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
ENDRA Life Sciences NDRA	-1.24 K	$ 3.36	-3.45 %	$ 1.8 M	USA
NeoGenomics NEO	82.4	$ 8.05	-0.62 %	$ 1.03 B	USA
CareDx, Inc CDNA	51.5	$ 17.58	0.11 %	$ 937 M	USA